These hubs can streamline access, reduce friction across reimbursement and logistics, and improve outcomes, as the CGT pipeline expands and patient demand accelerates.
Joe DePinto and Ela Lourido, McKesson
Advertisement
Articles by Joe DePinto and Ela Lourido, McKesson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Quality and Compliance in the Pharmaceutical Industry: Navigating a Transformed Landscape
2
FAQ: What Domestic Manufacturing Means for Drug Supply Chains
3
Designing Patient Hubs Purpose-Built for Cell and Gene Therapies
4
The Broken Business Model Driving America’s Pharmacy Deserts
5